Randomized trial demonstrates enhanced electrochemical detection of dopamine using a novel sensor platform, suggesting vast potential for clinical diagnostics.
The rapid and reliable detection of dopamine (DA) is crucial for clinical diagnostics and neurochemical research. Here, we present an advanced electrochemical sensor fabricated by integrating 3D printing technology with bimetallic nanomaterials to achieve high sensitivity, selectivity, and reproducibility. A conductive polylactic acid (PLA) electrode was 3D-printed and subsequently activated to expose electroactive carbon domains. The surface was then modified with AgPt bimetallic nanoparticles (NPs), synthesized via a one-step solvothermal method, and coated with NafionTM 117 to form the AgPt@A-3DPE sensor platform. Morphological and structural characterization confirmed the formation of uniform, quasi-spherical AgPt nanoparticles with excellent dispersion. The sensor exhibited outstanding electrochemical performance, including a wide linear detection range for DA (0.5–100 µM), a low limit of detection (LOD) of 0.037 µM, and a significantly enhanced electroactive surface area (1.04 cm2). Furthermore, it demonstrates high selectivity in complex matrices, with minimal interference from common biomolecules such as ascorbic acid, uric acid, and glucose. Moreover, the practical applicability of the AgPt@A-3DPE sensor was successfully validated through the analysis of real human urine samples. This work demonstrates a low-cost, scalable, and highly efficient sensing approach, opening new avenues for personalized diagnostics and real-time monitoring of neurotransmitters in biomedical applications.
No takes yet. Share an insight, caveat, or question.
Cirillo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: